Treatment of facial lipoatrophy in HIV-infected patients.
Standard management for facial lipoatrophy caused by antiretroviral drugs includes switching drugs and surgical autografting of adipose tissue. Local injections of polylactic acid have not been compared with surgery. Benefits usually seem to outweigh adverse effects in the short term but few long-term results are available.